CRISPR Therapeutics AG (CRSP) EBIT Margin (QoQ) (2016 - 2026)
CRISPR Therapeutics AG (CRSP) EBIT Margin (QoQ) (2016 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
CRISPR Therapeutics AG |
5.21 Bn |
2.76 Bn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
897,917.00 |
| Dec 31, 2025 |
-305,772.00 |
| Sep 30, 2025 |
1.09 Mn |
| Jun 30, 2025 |
-855,012.00 |
| Mar 31, 2025 |
-1.70 Mn |
| Dec 31, 2024 |
1.81 Mn |
| Sep 30, 2024 |
1.10 Mn |
| Jun 30, 2024 |
-136,301.00 |
| Mar 31, 2024 |
-2.79 Mn |
| Jun 30, 2023 |
-7,155.00 |
| Mar 31, 2023 |
219.23 Mn |
| Dec 31, 2022 |
-199.83 Mn |
| Sep 30, 2022 |
-7.80 Mn |
| Jun 30, 2022 |
-9.73 Mn |
| Mar 31, 2022 |
-1.76 Mn |
| Dec 31, 2021 |
1.45 Mn |
| Sep 30, 2021 |
-1.57 Mn |
| Jun 30, 2021 |
2.13 Mn |
| Mar 31, 2021 |
787,357.00 |
| Dec 31, 2020 |
3.33 Mn |
